Skip to Content

Tivorbex Approval History

  • FDA approved: Yes (First approved February 24th, 2014)
  • Brand name: Tivorbex
  • Generic name: indomethacin
  • Dosage form: Capsules
  • Company: Iroko Pharmaceuticals, LLC
  • Treatment for: Pain

Tivorbex (indomethacin) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of mild to moderate acute pain.

Development History and FDA Approval Process for Tivorbex

Feb 25, 2014Approval Iroko Pharmaceuticals Receives FDA Approval for Tivorbex

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.